Catalyst Funds Management’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-8,600	Closed	-$85.2K	–	1181
2024 Q1	$85.2K	Buy	+8,600	New	+$85.2K	0.02%	436